Showing results (11-20 of 731) with videos related to

Sort By:
Pageof 74
Frontiers in Pharmacology|June 2, 2020
The Use of Beta Blockers in Takotsubo Syndrome as Compared to Acute Coronary SyndromeMarvin Kummer, Ibrahim El-Battrawy, Thorsten Gietzen, et al.
Archives of Medical Science : AMS|May 17, 2024
Discriminating factors excluding patients from a catheter-based left atrial appendage closure and an outcome analysis of non-intervened and intervened patientsChristian Fastner, Claude Jabbour, Michael Behnes, et al.
Cardiovascular & Hematological Disorders Drug Targets|December 16, 2015
Novel Oral Anticoagulation Laboratory Monitoring, Interaction and Treatment of ComplicationsAydin Huseynov, Stefan Baumann, Ibrahim El-Battrawy, et al.
Cardiovascular & Hematological Disorders Drug Targets|December 16, 2015
New Oral Anticoagulation after Heart Valve ReplacementIbrahim El-Battrawy, Stefan Baumann, Aydin Huseynov, et al.
Herzschrittmachertherapie & Elektrophysiologie|April 27, 2023
[Asymptomatic channelopathies : Risk stratification and primary prophylaxis]Assem Aweimer, Andreas Mügge, Ibrahim Akin, et al.
Clinical Cardiology|April 15, 2017
Procedural success and intra-hospital outcome related to left atrial appendage morphology in patients that receive an interventional left atrial appendage closureChristian Fastner, Michael Behnes, Benjamin Sartorius, et al.
Scientific Reports|November 14, 2019
Takotsubo syndrome and cardiac implantable electronic device therapyIbrahim El-Battrawy, Julia W Erath, Siegfried Lang, et al.
In Vivo (Athens, Greece)|November 4, 2020
Association Between Mortality and Left Ventricular Ejection Fraction in Patients With Takotsubo Syndrome Versus Acute Coronary SyndromeMohammad Abumayyaleh, Ibrahim El-Battrawy, Marvin Kummer, et al.
The Canadian Journal of Cardiology|April 7, 2020
Improved Outcome of Cardiogenic Shock Triggered by Takotsubo Syndrome Compared With Myocardial InfarctionKatherine Sattler, Ibrahim El-Battrawy, Thorsten Gietzen, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|March 30, 2022
Hemodynamic Effects of Sacubitril/Valsartan in Patients with Reduced Left Ventricular Ejection Fraction Over 24 Months: A Retrospective StudyMohammad Abumayyaleh, Jonathan Demmer, Carina Krack, et al.
Pageof 74